VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.370
-0.004 (-1.12%)
At close: Dec 5, 2025, 4:00 PM EST
0.366
-0.004 (-1.19%)
After-hours: Dec 5, 2025, 7:38 PM EST
VYNE Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 19.35 | 19.93 | 30.62 | 30.91 | 42.25 | 57.56 | Upgrade
|
| Short-Term Investments | 13.35 | 41.59 | 62.63 | - | - | 1.03 | Upgrade
|
| Cash & Short-Term Investments | 32.7 | 61.52 | 93.25 | 30.91 | 42.25 | 58.59 | Upgrade
|
| Cash Growth | -53.41% | -34.03% | 201.71% | -26.85% | -27.89% | -18.75% | Upgrade
|
| Accounts Receivable | - | - | - | - | 7.58 | 15.82 | Upgrade
|
| Other Receivables | - | - | - | 5 | - | - | Upgrade
|
| Receivables | - | - | - | 5 | 7.58 | 15.82 | Upgrade
|
| Inventory | - | - | - | - | - | 7.4 | Upgrade
|
| Prepaid Expenses | 3.19 | 2.92 | 2.66 | 2.3 | 4.57 | 4.59 | Upgrade
|
| Restricted Cash | - | - | 0.05 | 0.07 | 0.61 | 0.86 | Upgrade
|
| Other Current Assets | - | - | - | - | 8.18 | - | Upgrade
|
| Total Current Assets | 35.89 | 64.44 | 95.96 | 38.28 | 63.19 | 87.26 | Upgrade
|
| Property, Plant & Equipment | 0.1 | 0.21 | 0.21 | - | 0.35 | 2.14 | Upgrade
|
| Other Long-Term Assets | 0.15 | 2.26 | 1.52 | 2.48 | 3.51 | 4.35 | Upgrade
|
| Total Assets | 36.13 | 66.91 | 97.69 | 40.76 | 67.05 | 93.74 | Upgrade
|
| Accounts Payable | 1.2 | 2.71 | 1.66 | 2.39 | 6.51 | 4.78 | Upgrade
|
| Accrued Expenses | 2.85 | 8.59 | 3.51 | 4.26 | 6.06 | 10.32 | Upgrade
|
| Current Portion of Leases | - | 0.1 | 0.12 | - | 0.35 | 0.76 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 5.8 | Upgrade
|
| Other Current Liabilities | - | 3.42 | 2.25 | 2.7 | 5.49 | 0.1 | Upgrade
|
| Total Current Liabilities | 4.04 | 14.82 | 7.54 | 9.35 | 18.41 | 21.77 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 33.17 | Upgrade
|
| Long-Term Leases | - | - | 0.1 | - | - | 0.85 | Upgrade
|
| Other Long-Term Liabilities | - | - | 1.31 | - | - | 0.46 | Upgrade
|
| Total Liabilities | 4.04 | 14.82 | 8.95 | 9.35 | 18.41 | 56.25 | Upgrade
|
| Common Stock | 0 | 0 | 0 | - | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 784.9 | 783.24 | 780.04 | 693.94 | 688.16 | 603.69 | Upgrade
|
| Retained Earnings | -752.82 | -731.17 | -691.34 | -662.74 | -639.53 | -566.2 | Upgrade
|
| Comprehensive Income & Other | 0 | 0.02 | 0.03 | - | - | - | Upgrade
|
| Total Common Equity | 32.09 | 52.09 | 88.74 | 31.2 | 48.64 | 37.49 | Upgrade
|
| Shareholders' Equity | 32.09 | 52.09 | 88.74 | 31.41 | 48.64 | 37.49 | Upgrade
|
| Total Liabilities & Equity | 36.13 | 66.91 | 97.69 | 40.76 | 67.05 | 93.74 | Upgrade
|
| Total Debt | - | 0.1 | 0.21 | - | 0.35 | 34.78 | Upgrade
|
| Net Cash (Debt) | 32.7 | 61.42 | 93.04 | 30.91 | 41.9 | 23.81 | Upgrade
|
| Net Cash Growth | -53.33% | -33.99% | 201.02% | -26.24% | 76.01% | -36.75% | Upgrade
|
| Net Cash Per Share | 0.77 | 1.44 | 9.06 | 9.70 | 14.66 | 13.22 | Upgrade
|
| Filing Date Shares Outstanding | 33.04 | 15.21 | 14.1 | 3.26 | 3.12 | 2.85 | Upgrade
|
| Total Common Shares Outstanding | 31.77 | 14.83 | 14.1 | 3.23 | 2.98 | 2.4 | Upgrade
|
| Working Capital | 31.84 | 49.62 | 88.43 | 28.93 | 44.78 | 65.49 | Upgrade
|
| Book Value Per Share | 1.01 | 3.51 | 6.29 | 9.66 | 16.34 | 15.62 | Upgrade
|
| Tangible Book Value | 32.09 | 52.09 | 88.74 | 31.2 | 48.64 | 37.49 | Upgrade
|
| Tangible Book Value Per Share | 1.01 | 3.51 | 6.29 | 9.66 | 16.34 | 15.62 | Upgrade
|
| Machinery | 0.12 | 0.12 | - | - | 0.85 | 0.94 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.06 | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.